Refining Prognostic Assessment in Elderly Non-small Cell Lung Cancer: The Importance of Dynamic Comorbidities and Comprehensive Biomarker Profiling.
0/5 보강
APA
Huang F, Fang M (2026). Refining Prognostic Assessment in Elderly Non-small Cell Lung Cancer: The Importance of Dynamic Comorbidities and Comprehensive Biomarker Profiling.. Clinical oncology (Royal College of Radiologists (Great Britain)), 49, 103969. https://doi.org/10.1016/j.clon.2025.103969
MLA
Huang F, et al.. "Refining Prognostic Assessment in Elderly Non-small Cell Lung Cancer: The Importance of Dynamic Comorbidities and Comprehensive Biomarker Profiling.." Clinical oncology (Royal College of Radiologists (Great Britain)), vol. 49, 2026, pp. 103969.
PMID
41308322 ↗
같은 제1저자의 인용 많은 논문 (5)
- Safety and Efficacy of Cyclophosphamide With Dual Mecapegfilgrastim and On-Demand Plerixafor for Salvage Mobilization in Patients With Initial Mobilization Failure: A Retrospective Cohort.
- Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer.
- Comments on "p53 regulates glucose metabolic reprogramming in MASLD-related hepatocellular carcinoma via modulating mitochondrial pyruvate carriers".
- Association between hot beverage intake and gastric cancer risk: a prospective cohort study from the UK Biobank.
- Expression and clinical significance of TEM8 protein in triple-negative breast cancer.